Javier Angulo Frutos;Maria Luisa Krauel;Serafin Valverde Lopez;Antonio Romero Garrido;Guillermo Gimenez Gallego;Rosa Maria Lozano Puerto;Inigo Saenz de Tejada Morgan;Pedro Cuevas Sánchez
发明人:
Pedro Cuevas Sánchez,Guillermo Gimenez Gallego,Inigo Saenz de Tejada Morgan,Maria Luisa Krauel,Javier Angulo Frutos,Rosa Maria Lozano Puerto,Antonio Romero Garrido,Serafin Valverde Lopez
申请号：
US12986674
公开号：
US20120015912A1
申请日:
2011.01.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to the use of a compound of Formula (IIV) or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of any of the diseases selected from the group consisting of macular degeneration, corneal neovascularization or angiogenesis, iris neovascularization or angiogenesis, retinal neovascularization or angiogenesis, diabetic proliferative retinopathy and non-diabetic proliferative retinopathy.
